Adult Endogenous Dopaminergic Neuroregeneration Against Parkinson’s Disease: Ideal Animal Models?

Agid Y, Blin J Nerve cell death in degenerative diseases of the central nervous system: clinical aspects. In: Ciba Found Symp, 1987. Wiley Online Library, pp 3-29 Alvarez-Buylla A, Kirn JR, Nottebohm F (1990) Birth of projection neurons in adult avian brain may be related to perceptual or motor learning. Science 249:1444–1447 Anacker C, Denny CA, Hen R (2015) Regulation of hippocampal memory traces by neurogenesis. Neurogenesis 2:e1025180. https://doi.org/10.1080/23262133.2015.1025180 Andrew R, Watson D, Best S, Midgley J, Wenlong H et al (1993) The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res 18:1175–1177 Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O (2002) Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8:963–970 Assal F, Spahr L, Hadengue A, Rubbici-Brandt L, Burkhard PR (1998) Tolcapone and fulminant hepatitis. The Lancet 352:958. https://doi.org/10.1016/s0140-6736(05)61511-5 Baltazar T, Dinis-Oliveira RJ, Duarte JA, de Lourdes BM, Carvalho F (2013) Paraquat research: do recent advances in limiting its toxicity make its use safer? Br J Pharmacol 168:44–45 Banati RB, Daniel SE, Blunt SB (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson’s disease. Mov Disord 13:221–227 Banks WA (2016) From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov. https://doi.org/10.1038/nrd.2015.21 Barata-Antunes S, Teixeira FG, Mendes-Pinheiro B, Domingues AV, Vilaça-Faria H et al (2020) Impact of aging on the 6-OHDA-induced rat model of Parkinson’s disease. Int J Mol Sci 21:3459. https://doi.org/10.3390/ijms21103459 Barbosa JS, Sanchez-Gonzalez R, Di Giaimo R, Baumgart EV, Theis FJ et al (2015) Live imaging of adult neural stem cell behavior in the intact and injured zebrafish brain. Science 348:789–793 Barreiro-Iglesias A, Mysiak KS, Scott AL, Reimer MM, Yang Y et al (2015) Serotonin promotes development and regeneration of spinal motor neurons in zebrafish. Cell Rep 13:924–932 Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH et al (2003) White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol 60:393–398. https://doi.org/10.1001/archneur.60.3.393 Berg DA, Kirkham M, Beljajeva A, Knapp D, Habermann B et al (2010) Efficient regeneration by activation of neurogenesis in homeostatically quiescent regions of the adult vertebrate brain. Development 137:4127–4134 Berg DA, Kirkham M, Wang H, Frisén J, Simon A (2011) Dopamine controls neurogenesis in the adult salamander midbrain in homeostasis and during regeneration of dopamine neurons. Cell Stem Cell 8:426–433 Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV et al (2000) Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci 3:1301–1306 Blanchet PJ, Calon F, Morissette M, Tahar AH, Bélanger N et al (2004) Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms. Parkinsonism Relat D 10:297–304 Blesa J, Przedborski S (2014) Parkinson’s disease: animal models and dopaminergic cell vulnerability. Front Neuroanat 8:155 Bretaud S, Lee S, Guo S (2004) Sensitivity of zebrafish to environmental toxins implicated in Parkinson’s disease. Neurotoxicol Teratol 26:857–864 Büeler H (2009) Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson’s disease. Exp Neurol 218:235–246 Buhidma Y, Rukavina K, Chaudhuri KR, Duty S (2020) Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease. NPJ Parkinsons Dis 6:1–7 Busby ER, Roch GJ, Sherwood NM (2010) Endocrinology of zebrafish: a small fish with a large gene pool. In: Fish Physiology, vol 29. Elsevier, pp 173-247 Caldwell LJ, Davies NO, Cavone L, Mysiak KS, Semenova SA et al (2019) Regeneration of dopaminergic neurons in adult zebrafish depends on immune system activation and differs for distinct populations. J Neurosci 39:4694–4713 Caneda-Ferrón B, De Girolamo LA, Costa T, Beck KE, Layfield R et al (2008) Assessment of the direct and indirect effects of MPP+ and dopamine on the human proteasome: implications for Parkinson’s disease aetiology. J Neurochem 105:225–238 Cannon JR, Geghman KD, Tapias V, Sew T, Dail MK et al (2013) Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson’s disease features and enhances vulnerability to mitochondrial impairment. Exp Neurol 240:44–56 Cave JW, Baker H (2009) Dopamine systems in the forebrain. Development and Engineering of Dopamine Neurons. Springer , New York, NY, pp 15–35 Cenci MA, Ohlin KE, Rylander D (2009) Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia. Parkinsonism Relat D 15:S59–S63 Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5:235–245 Chen M, Reed RR, Lane AP (2017) Acute inflammation regulates neuroregeneration through the NF-κB pathway in olfactory epithelium. PNAS 114:8089–8094 Chen Y-C, Priyadarshini M, Panula P (2009) Complementary developmental expression of the two tyrosine hydroxylase transcripts in zebrafish. Histochem Cell Biol 132:375–381 Chernoff EA, Stocum DL, Nye HL, Cameron JA (2003) Urodele spinal cord regeneration and related processes. Dev Dyn 226:295–307 Choi SJ, Panhelainen A, Schmitz Y, Larsen KE, Kanter E et al (2015) Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure. J Biol Chem 290:6799–6809 Choi W-S, Palmiter RD, Xia Z (2011) Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease model. J Cell Biol 192:873–882 Church DM, Goodstadt L, Hillier LW, Zody MC, Goldstein S et al (2009) Lineage-specific biology revealed by a finished genome assembly of the mouse. PLoS Biol 7:e1000112. https://doi.org/10.1371/journal.pbio.1000112 Costa ROd, Gadelha-Filho CVJ, Costa AEMd, Feitosa ML, Araújo DPd et al (2017) The treadmill exercise protects against dopaminergic neuron loss and brain oxidative stress in parkinsonian rats. Oxid Med Cell Longev. https://doi.org/10.1155/2017/2138169 Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B (2009) Parkinson’s disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol 169:919–926 Crane AM, Bhattacharya SK (2013) The use of bromodeoxyuridine incorporation assays to assess corneal stem cell proliferation. In: Corneal Regenerative Medicine. Springer, pp 65-70 Curtis MA, Penney EB, Pearson AG, van Roon-Mom WM, Butterworth NJ et al (2003) Increased cell proliferation and neurogenesis in the adult human Huntington’s disease brain. PNAS 100:9023–9027 Da Fonseca TL, Correia A, Hasselaar W, Van Der Linde HC, Willemsen R et al (2013) The zebrafish homologue of Parkinson’s disease ATP13A2 is essential for embryonic survival. Brain Res Bull 90:118–126 Dass B, Iravani MM, Jackson M, Engber T, Galdes A et al (2002) Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated common marmosets. Neuroscience 114:99–109 Dawson TM, Golde TE, Lagier-Tourenne C (2018) Animal models of neurodegenerative diseases. Nat Neurosci 21:1370–1379 Dawson TM, Ko HS, Dawson VL (2010) Genetic animal models of Parkinson’s disease. Neuron 66:646–661 De Hemptinne C, Swann NC, Ostrem JL, Ryapolova-Webb ES, San Luciano M et al (2015) Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson’s disease. Nat Neurosci 18:779–786 de Oliveira-Carlos V, Ganz J, Hans S, Kaslin J, Brand M (2013) Notch receptor expression in neurogenic regions of the adult zebrafish brain. PLoS ONE 8:e73384. https://doi.org/10.1371/journal.pone.0073384 Du Y, Guo Q, Shan M, Wu Y, Huang S et al (2016) Spatial and temporal distribution of dopaminergic neurons during development in zebrafish. Front Neuroanat 10:115. https://doi.org/10.3389/fnana.2016.00115 Du Y, Zhang X, Tao Q, Chen S, Le W (2013) Adeno-associated virus type 2 vector-mediated glial cell line-derived neurotrophic factor gene transfer induces neuroprotection and neuroregeneration in a ubiquitin-proteasome system impairment animal model of Parkinson’s disease. Neurodegener Dis 11:113–128 Ehringer H, Hornykiewicz O (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wochenschr 38:1236–1239 Ekstrand MI, Galter D (2009) The MitoPark mouse–an animal model of Parkinson’s disease with impaired respiratory chain function in dopamine neurons. Parkinsonism Relat D 15:S185–S188 Elsworth J, Taylor J, Sladek J, Collier T, Redmond D et al (2000) Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience 95:399–408 Faivre F, Joshi A, Bezard E, Barrot M (2019) The hidden side of Parkinson’s disease: studying pain, anxiety and depression in animal models. Neurosci Biobehav Rev 96:335–352 Felten DL, Sladek JR Jr (1983) Monoamine distribution in primate brain V. Monoaminergic nuclei: anatomy, pathways and local organization. Brain Res Bull 10:171–284 Ferrari E, Capucciati A, Prada I, Zucca FA, D’Arrigo G et al (2017) Synthesis, structure characterization, and evaluation in microglia cultures of neuromelanin analogues suitable for modeling Parkinson’s disease. ACS Chem Neurosci 8:501–512 Fleming SM, Zhu C, Fernagut P-O, Mehta A, DiCarlo CD et al (2004) Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp Neurol 187:418–429 French V, Bryant PJ, Bryant SV (1976) Pattern regulation in epimorphic fields. Science 193:969–981 Freundlieb N, François C, Tandé D, Oertel WH, Hirsch EC et al (2006) Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates. J Neurosci 26:2321–2325 Galant S, Furlan G, Coolen M, Dirian L, Foucher I et al (2016) Embryonic origin and lineage hierarchies of the neural progenitor subtypes building the zebrafish adult midbrain. Dev Biol 420:120–135 Garbayo E, Ansorena E, Lana H, del Mar C-A, Marcilla I et al (2016) Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys. Biomaterials 110:11–23 Gash DM, Zhang Z, Ai Y, Grondin R, Coffey R et al (2005) Trophic factor distribution predicts functional recovery in parkinsonian monkeys. Ann Neurol 58:224–233 Godwin JW, Pinto AR, Rosenthal NA (2013) Macrophages are required for adult salamander limb regeneration. PNAS 110:9415–9420 Götz M, Barde Y-A (2005) Radial glial cells: defined and major intermediates between embryonic stem cells and CNS neurons. Neuron 46:369–372 Grant HC, Lantos P, Parkinson C (1980) Cerebral damage in paraquat poisoning. Histopathology 4:185–195 Grimmig B, Daly L, Subbarayan M, Hudson C, Williamson R et al (2018) Astaxanthin is neuroprotective in an aged mouse model of Parkinson’s disease. Oncotarget 9:10388. https://doi.org/10.18632/oncotarget.23737 Grondin R, Zhang Z, Yi A, Cass WA, Maswood N et al (2002) Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 125:2191–2201 Hafkemeijer A, Altmann-Schneider I, de Craen AJ, Slagboom PE, van der Grond J et al (2014) Associations between age and gray matter volume in anatomical brain networks in middle-aged to older adults. Aging Cell 13:1068–1074 Haines DE Neuroanatomy: an atlas of structures, sections, and systems vol 153. vol 2004. Lippincott Williams & Wilkins, Hameed LS, Berg DA, Belnoue L, Jensen LD, Cao Y et al (2015) Environmental changes in oxygen tension reveal ROS-dependent neurogenesis and regeneration in the adult newt brain. Elife 4:34. https://doi.org/10.7554/eLife.08422 Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T (2016) The incidence of Parkinson’s disease: a systematic review and meta-analysis. Neuroepidemiology 46:292–300 Hosamani R, Krishna G, Muralidhara, (2016) Standardized Bacopa monnieri extract ameliorates acute paraquat-induced oxidative stress, and neurotoxicity in prepubertal mice brain. Nutr Neurosci 19:434–446 Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C et al (2013) The zebrafish reference genome sequence and its relationship to the human genome. Nature 496:498–503 Hruscha A, Krawitz P, Rechenberg A, Heinrich V, Hecht J et al (2013) Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish. Development 140:4982–4987 Huang H, Chen L (2015) Neurorestorative process, law, and mechanisms. Journal of Neurorestoratology 3:23–30. https://doi.org/10.2147/JN.S74139 Imokawa Y, Simon A, Brockes JP (2004) A critical role for thrombin in vertebrate lens regeneration. Philosophical Transactions of the Royal Society of London B: Biological Sciences 359:765–776 Jackson-Lewis V, Przedborski S (2007) Protocol for the MPTP mouse model of Parkinson’s disease. Nat Protoc 2:141–151 Joers V, Tansey MG, Mulas G, Carta AR (2017) Microglial phenotypes in Parkinson’s disease and animal models of the disease. Prog Neurobiol 155:57–75 Kah O, Chambolle P, Thibault J, Geffard M (1984) Existence of dopaminergic neurons in the preoptic region of the goldfish. Neurosci Lett 48:293–298 Kalueff AV, Stewart AM, Gerlai R (2014) Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol Sci 35:63–75 Kaslin J, Kroehne V, Benato F, Argenton F, Brand M (2013) Development and specification of cerebellar stem and progenitor cells in zebrafish: from embryo to adult. Neural Dev 8:9. https://doi.org/10.1186/1749-8104-8-9 Kaslin J, Panula P (2001) Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (Danio rerio). Journal of Comparative Neurology 440:342–377 Kastner A, Hirsch E, Lejeune O, Javoy-Agid F, Rascol O et al (1992) Is the vulnerability of neurons in the substantia nigra of patients with Parkinson’s disease related to their neuromelanin content? J Neurochem 59:1080–1089 Kells AP, Eberling J, Su X, Pivirotto P, Bringas J et al (2010) Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF. J Neurosci 30:9567–9577 Kirkham M, Berg DA, Simon A (2011) Microglia activation during neuroregeneration in the adult vertebrate brain. Neurosci Lett 497:11–16 Kirkham M, Joven A (2015) Studying newt brain regeneration following subtype specific neuronal ablation. Salamanders in Regeneration Research: Methods and Protocols 1290:91–99 Kishimoto N, Shimizu K, Sawamoto K (2012) Neuronal regeneration in a zebrafish model of adult brain injury. Dis Model Mech 5:200–209 Kizil C, Kaslin J, Kroehne V, Brand M (2012) Adult neurogenesis and brain regeneration in zebrafish. Dev Neurobiol 72:429–461 Konieczny J, Czarnecka A, Lenda T, Kamińska K, Antkiewicz-Michaluk L (2017) The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: a comparative study of lactacystin and 6-OHDA. Neuroscience 340:308–318 Kriks S, Shim J-W, Piao J, Ganat YM, Wakeman DR et al (2011) Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature 480:547–551 Kumar A, Leinisch F, Kadiiska MB, Corbett J, Mason RP (2016) Formation and implications of alpha-synuclein radical in maneb-and paraquat-induced models of Parkinson’s disease. Mol Neurobiol 53:2983–2994 Kyritsis N, Kizil C, Zocher S, Kroehne V, Kaslin J et al (2012) Acute inflammation initiates the regenerative response in the adult zebrafish brain. Science 338:1353–1356 LaMonica BE, Lui JH, Hansen DV, Kriegstein AR (2013) Mitotic spindle orientation predicts outer radial glial cell generation in human neocortex. Nat Commun 4:1665. https://doi.org/10.1038/ncomms2647 Langston J, Forno L, Tetrud J, Reeves A, Kaplan J et al (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine exposure. Ann Neurol 46:598–605 Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979–980 Lazarini F, Gabellec M-M, Moigneu C, De Chaumont F, Olivo-Marin J-C et al (2014) Adult neurogenesis restores dopaminergic neuronal loss in the olfactory bulb. J Neurosci 34:14430–14442 LeClair EE, Topczewski J (2010) Development and regeneration of the zebrafish maxillary barbel: a novel study system for vertebrate tissue growth and repair. PLoS ONE 5:e8737. https://doi.org/10.1371/journal.pone.0008737 Lee DA, Yoo S, Pak T, Salvatierra J, Velarde E et al (2014) Dietary and sex-specific factors regulate hypothalamic neurogenesis in young adult mice. Front Neurosci 8:157. https://doi.org/10.3389/fnins.2014.00157 Li C, Jackson RM (2002) Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 282:C227–C241 Liao C-H, Chen S-Y, Kuo J-S, Pang C-Y (2013) Reduction of motor disorder in 6-OHDA-induced severe parkinsonism rats by post treatment with granulocyte-colony stimulating factor. Chin J Physiol 56:147–154 Lim KL, Ng CH (2009) Genetic models of Parkinson disease. Biochim Biophys Acta-Molecular Basis of Disease 1792:604–615 Lindsey BW, Darabie A, Tropepe V (2012) The cellular composition of neurogenic periventricular zones in the adult zebrafish forebrain. Journal of Comparative Neurology 520:2275–2316 Lindsey BW, Hall ZJ, Heuzé A, Joly J-S, Tropepe V et al (2018) The role of neuro-epithelial-like and radial-glial stem and progenitor cells in development, plasticity, and repair. Prog Neurobiol 170:99–114 Lu X-H, Fleming SM, Meurers B, Ackerson LC, Mortazavi F et al (2009) Bacterial artificial chromosome transgenic mice expressing a truncated mutant Parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant α-synuclein. J Neurosci 29:1962–1976 Luthman J, Fredriksson A, Sundström E, Jonsson G, Archer T (1989) Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage. Behav Brain Res 33:267–277 Maheras AL, Dix B, Carmo OM, Young AE, Gill VN et al. (2018) Genetic pathways of neuroregeneration in a novel mild traumatic brain injury model in adult zebrafish. eNeuro 5:ENEURO. 0208–0217.2017 doi:https://doi.org/10.1523/ENEURO.0208-17.2017. Matsui H (2017) Dopamine system, cerebellum, and nucleus ruber in fish and mammals. Dev Growth Differ 59:219–227 Mattam U, Jagota A (2015) Daily rhythms of serotonin metabolism and the expression of clock genes in suprachiasmatic nucleus of rotenone-induced Parkinson’s disease male Wistar rat model and effect of melatonin administration. Biogerontology 16:109–123 McGeer PL, Itagaki S, Boyes BE, McGeer E (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 38:1285–1285 Merkle FT, Mirzadeh Z, Alvarez-Buylla A (2007) Mosaic organization of neural stem cells in the adult brain. Science 317:381–384 Mochizuki H (2011) Adult neurogenesis in Parkinson’s disease. Neurogenesis in the Adult Brain II. Springer, Tokyo, pp 23–36 Moreira CG, Barbiero JK, Ariza D, Dombrowski PA, Sabioni P et al (2012) Behavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a new approach for an old neurotoxin. Neurotox Res 21:291–301 Morest DK (1970) A study of neurogenesis in the forebrain of opossum pouch young. Zeitschrift für Anatomie und Entwicklungsgeschichte 130:265–305 Morin N, Grégoire L, Gomez-Mancilla B, Gasparini F, Di Paolo T (2010) Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys. Neuropharmacology 58:981–986 Muñoz-Manchado AB, Villadiego J, Romo-Madero S, Suárez-Luna N, Bermejo-Navas A et al (2016) Chronic and progressive Parkinson’s disease MPTP model in adult and aged mice. J Neurochem 136:373–387 Nandhagopal R, McKeown MJ, Stoessl AJ (2008) Invited article: functional imaging in Parkinson disease. Neurology 70:1478–1488 Naughton C, O’Toole D, Kirik D, Dowd E (2017) Interaction between subclinical doses of the Parkinson’s disease associated gene, α-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats. Behav Brain Res 316:160–168 Nonnekes J, Timmer MH, Vries NM, Rascol O, Helmich RC et al (2016) Unmasking levodopa resistance in Parkinson’s disease. Mov Disord 31:1602–1609 Noristani H, Meadows R, Olabarria M, Verkhratsky A, Rodríguez J (2011) Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer’s disease: an ultrastructural study. Cell Death Dis 2:e210. https://doi.org/10.1038/cddis.2011.79 Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann G et al (2003) Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med 9:439–447 Nunes ME, Müller TE, Braga MM, Fontana BD, Quadros VA et al (2016) Chronic treatment with paraquat induces brain injury, changes in antioxidant defenses system, and modulates behavioral functions in zebrafish. Mol Neurobiol 54:3925–3934 Nyholm D, Askmark H, Gomes-Trolin C, Knutson T, Lennernäs H et al (2003) Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets. Clin Neuropharmacol 26:156–163 O’Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L et al (2008) Nonmotor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study. Mov Disord 23:101–106 Okun MS (2012) Deep-brain stimulation for Parkinson’s disease. N Engl J Med 367:1529–1538 Olanow CW (2000) Tolcapone and hepatotoxic effects. Arch Neurol 57:263–267 Padel T, Özen I, Boix J, Barbariga M, Gaceb A et al (2016) Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson’s disease. Neurobiol Dis 94:95–105 Palfi S, Leventhal L, Chu Y, Ma SY, Emborg M et al (2002) Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J Neurosci 22:4942–4954 Paredes-Rodriguez E, Vegas-Suarez S, Morera-Herreras T, De Deurwaerdere P, Miguelez C (2020) The noradrenergic system in Parkinson’s disease. Front Pharmacol. https://doi.org/10.3389/fphar.2020.00435 Parent A, Levesque M, Parent M (2001) A re-evaluation of the current model of the basal ganglia. Parkinsonism Relat D 7:193–198 Parent JM, Vexler ZS, Gong C, Derugin N, Ferriero DM (2002) Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann Neurol 52:802–813 Parish CL, Beljajeva A, Arenas E, Simon A (2007) Midbrain dopaminergic neurogenesis and behavioural recovery in a salamander lesion-induced regeneration model. Development 134:2881–2887 Parker MO, Brock AJ, Walton RT, Brennan CH (2014) The role of zebrafish (Danio rerio) in dissecting the genetics and neural circuits of executive function. Frontiers in Neural Circuits 7:63. https://doi.org/10.3389/fncir.2013.00063 Patton EE, Zon LI (2001) The art and design of genetic screens: zebrafish. Nat Rev Genet 2:956–966 Perese D, Ulman J, Viola J, Ewing S, Bankiewicz K (1989) A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res 494:285–293 Petkó M, Orosz V (1996) Distribution of somatostatin-immunoreactive structures in the central nervous system of the frog, Rana esculenta. J Hirnforsch 37:109–120 Petzinger GM, Fisher B, Hogg E, Abernathy A, Arevalo P et al (2006) Behavioral motor recovery in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): Changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins. J Neurosci Res 83:332–347 Politis M, Wu K, Loane C, Quinn NP, Brooks DJ et al (2010) Serotonergic neurons mediate dyskinesia side effects in Parkinson’s patients with neutral transplants. Sci Transl Med 2:38ra46-38ra46 Pont-Sunyer C, Hotter A, Gaig C, Seppi K, Compta Y et al (2015) The onset of nonmotor symptoms in Parkinson’s disease (the ONSET PD study). Mov Disord 30:229–237 Potashkin J, Blume S, Runkle N (2010) Limitations of animal models of Parkinson’s disease. Parkinson’s Dis. https://doi.org/10.4061/2011/658083 Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G et al (2001) The parkinsonian toxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76:1265–1274 Przedborski S, Vila M (2003) The 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model. Ann N Y Acad Sci 991:189–198 Przedbroski S, Leviver M, Jiang H, Ferreira M, Jackson-Lewis V et al (1995) Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by instrastriatal injection of 6-hydroxydopamine. Neuroscience 67:631–647 Ramachandran R, Zhao X-F, Goldman D (2011) Ascl1a/Dkk/β-catenin signaling pathway is necessary and glycogen synthase kinase-3β inhibition is sufficient for zebrafish retina regeneration. PNAS 108:15858–15863 Razgado-Hernandez LF, Espadas-Alvarez AJ, Reyna-Velazquez P, Sierra-Sanchez A, Anaya-Martinez V et al (2015) The transfection of BDNF to dopamine neurons potentiates the effect of dopamine D3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson’s disease. PLoS ONE 10:e0117391. https://doi.org/10.1371/journal.pone.0117391 Riederer P (1976) Time course of nigrostriatal degeneration in Parkinson’s disease. J Neural Transm 38:277–301 Rink E, Wullimann MF (2001) The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res 889:316–330 Rojo AI, Cavada C, de Sagarra MR, Cuadrado A (2007) Chronic inhalation of rotenone or paraquat does not induce Parkinson’s disease symptoms in mice or rats. Exp Neurol 208:120–126 Roth BL, Zanettini R, Antonini A, Gatto G, Gentile R et al (2007) Valvular heart disease and the use of dopamine agonists for Parkinson’s disease. N Engl J Med. https://doi.org/10.1056/NEJMoa054830 Rothenaigner I, Krecsmarik M, Hayes JA, Bahn B, Lepier A et al (2011) Clonal analysis by distinct viral vectors identifies bona fide neural stem cells in the adult zebrafish telencephalon and characterizes their division properties and fate. Development 138:1459–1469 Sachs C, Jonsson G (1975) Mechanisms of action of 6-hydroxydopamine. Biochem Pharmacol 24:1–8 S Salari S, Bagheri M (2019) In vivo, in vitro and pharmacologic models of Parkinson's disease. Physiol Res 68 Sánchez-Camacho C, Marín O, Smeets WJ, Ten Donkelaar HJ, González A (2001) Descending supraspinal pathways in amphibians. II. Distribution and origin of the catecholaminergic innervation of the spinal cord. Journal of Comparative Neurology 434:209–232 Santiago RM, Barbieiro J, Lima MM, Dombrowski PA, Andreatini R et al (2010) Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson’s disease are predominantly associated with serotonin and dopamine. Prog Neuropsychopharmacol Biol Psychiatry 34:1104–1114 Sarath Babu N, Murthy CLN, Kakara S, Sharma R, Swamy B et al (2016) 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced Parkinson’s disease in zebrafish. Proteomics 16:1407–1420 Schlachetzki JC, Winkler J (2015) The innate immune system in Parkinson’s disease: a novel target promoting endogenous neuroregeneration. Neural Regen Res 10:704–706 Schmidt N, Ferger B (2001) Neurochemical findings in the MPTP model of Parkinson’s disease. J Neural Transm 108:1263–1282 Schmidt R, Strahle U, Scholpp S (2013) Neurogenesis in zebrafish-from embryo to adult. Neural Dev 8:8104–8108 Schmitz Y, Castagna C, Mrejeru A, Lizardi-Ortiz JE, Klein Z et al (2013) Glycine transporter-1 inhibition promotes striatal axon sprouting via NMDA receptors in dopamine neurons. J Neurosci 33:16778–16789 Schober A (2004) Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP. Cell Tissue Res 318:215–224 Senoh S, Creveling CR, Udenfriend S, Witkop B (1959) Chemical, enzymatic and metabolic studies on the mechanism of oxidation of dopamine1. J Am Chem Soc 81:6236–6240 Senoh S, Witkop B (1959) Non-enzymatic conversions of dopamine to norepinephrine and trihydroxyphenethylamines1. J Am Chem Soc 81:6222–6231 Shimizu K, Ohtaki K, Matsubara K, Aoyama K, Uezono T et al (2001) Carrier-mediated processes in blood–brain barrier penetration and neural uptake of paraquat. Brain Res 906:135–142 Sidorova YA, Volcho KP, Salakhutdinov NF (2019) Neuroregeneration in Parkinson’s disease: from proteins to small molecules. Curr Neuropharmacol 17:268–287 Simon A, Berg D, Kirkham M Not lost in translation: Sensing the loss and filling the gap during regeneration. In: Seminars in Cell & Developmental Biology, 2009. vol 6. Elsevier, pp 691-696 Somayajulu-Niţu M, Sandhu JK, Cohen J, Sikorska M, Sridhar T et al (2009) Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q 10. BMC Neurosci 10:88. https://doi.org/10.1186/1471-2202-10-88 Sotoyama H, Iwakura Y, Oda K, Sasaoka T, Takei N et al (2017) Striatal hypodopamine phenotypes found in transgenic mice that overexpress glial cell line-derived neurotrophic factor. Neurosci Lett 654:99–106 Stamatovic SM, Martinez-Revollar G, Hu A, Choi J, Keep RF et al (2019) Decline in Sirtuin-1 expression and activity plays a critical role in blood-brain barrier permeability in aging. Neurobiol Dis 126:105–116 Steinbeck JA, Choi SJ, Mrejeru A, Ganat Y, Deisseroth K et al (2015) Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson’s disease model. Nat Biotechnol 33:204–209 Strand NS, Hoi KK, Phan TM, Ray CA, Berndt JD et al (2016) Wnt/β-catenin signaling promotes regeneration after adult zebrafish spinal cord injury. Biochem Biophys Res Commun 477:952–956 Tabar V, Studer L (2014) Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nat Rev Genet 15:82–92 Tandé D, Höglinger G, Debeir T, Freundlieb N, Hirsch EC et al (2006) New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis. Brain 129:1194–1200 Tay TL, Ronneberger O, Ryu S, Nitschke R, Driever W (2011) Comprehensive catecholaminergic projectome analysis reveals single-neuron integration of zebrafish ascending and descending dopaminergic systems. Nat Commun 2:171. https://doi.org/10.1038/ncomms1171 Than-Trong E, Bally-Cuif L (2015) Radial glia and neural progenitors in the adult zebrafish central nervous system. Glia 63:1406–1428 Thiruchelvam M, Powers J, Cory-Slechta D, Richfield E (2004) Risk factors for dopaminergic neuron loss in human α-synuclein transgenic mice. Eur J Neurosci 19:845–854 Tillet Y (1994) Catecholaminergic neuronal systems in the diencephalon of mammals, vol 207. Cambridge University Press, Cambridge Tintner R, Manian P, Gauthier P, Jankovic J (2005) Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson disease. Arch Neurol 62:1290–1295 Tranzer J, Thoenen H (1968) An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine. Experientia 24:155–156 Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. Aging Cell 18:e13031. https://doi.org/10.1111/acel.13031 Van Kampen JM, Eckman CB (2006) Dopamine D3 receptor agonist delivery to a model of Parkinson’s disease restores the nigrostriatal pathway and improves locomotor behavior. J Neurosci 26:7272–7280 Vecchia DD, Schamne MG, Ferro MM, Santos AFCd, Latyki CL et al (2015) Effects of Hypericum perforatum on turning behavior in an animal model of Parkinson’s disease. Braz J Pharm Sci 51:111–115 Vijayanathan Y, Lim FT, Lim SM, Long CM, Tan MP et al (2017) 6-OHDA-lesioned adult zebrafish as a useful Parkinson’s disease model for dopaminergic neuroregeneration. Neurotox Res 32:496–508 Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M et al (2000) α-Synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem 74:721–729 Wan J, Goldman D (2016) Retina regeneration in zebrafish. Curr Opin Genet Dev 40:41–47 Wang Y, Liu W, Yang J, Wang F, Sima Y et al (2017) Parkinson’s disease-like motor and non-motor symptoms in rotenone-treated zebrafish. NeuroToxicology 58:103–109 Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13:1045–1060 Worlitzer MM, Viel T, Jacobs AH, Schwamborn JC (2013) The majority of newly generated cells in the adult mouse substantia nigra express low levels of doublecortin, but their proliferation is unaffected by 6-OHDA-induced nigral lesion or minocycline-mediated inhibition of neuroinflammation. Eur J Neurosci 38:2684–2692 Xi Y, Noble S, Ekker M (2011) Modeling neurodegeneration in zebrafish. Curr Neurol Neurosci Rep 11:274–282 Xu K, Di Luca D, Orrú M, Xu Y, Chen J-F et al (2016) Neuroprotection by caffeine in the MPTP model of Parkinson’s disease and its dependence on adenosine A2A receptors. Neuroscience 322:129–137 Yamamoto K, Vernier P (2011) The evolution of dopamine systems in chordates. Front Neuroanat 5:21. https://doi.org/10.3389/fnana.2011.00021 Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S et al (2007) Valvular heart disease and the use of dopamine agonists for Parkinson’s disease. N Engl J Med 356:39–46 Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337–341 Zecca L, Wilms H, Geick S, Claasen J-H, Brandenburg L-O et al (2008) Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson’s disease. Acta Neuropathol 116:47–55 Zhang W, Phillips K, Wielgus AR, Liu J, Albertini A et al (2011) Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson’s disease. Neurotox Res 19:63–72 Zhao Y-Z, Jin R-R, Yang W, Xiang Q, Yu W-Z et al (2016) Using gelatin nanoparticle mediated intranasal delivery of neuropeptide substance P to enhance neuro-recovery in hemiparkinsonian rats. PLoS ONE 11:e0148848. https://doi.org/10.1371/journal.pone.0148848 Zhu C, Vourc’h P, Fernagut PO, Fleming SM, Lacan S et al (2004) Variable effects of chronic subcutaneous administration of rotenone on striatal histology. Journal of Comparative Neurology 478:418–426 Zucca FA, Segura-Aguilar J, Ferrari E, Muñoz P, Paris I et al (2017) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson’s disease. Prog Neurobiol 155:96–119 Zucca FA, Vanna R, Cupaioli FA, Bellei C, De Palma A et al (2018) Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson’s disease. NPJ Parkinsons Dis 4:1–23